Comparing Direct vs Indirect Methods for Cascade Screening

Recruiting N/A Interventional Study
Long QT Syndrome Familial Hypercholesterolemia Ethics Genetic Testing
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Screening
Participants needed
200 (estimated)
Sponsor
University of Maryland, Baltimore · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
An important aspect of successful genomic medicine implementation is developing effective approaches for screening at-risk family members after probands are identified, also known as cascade screening. Most cascade screening studies conducted to date have been conducted outside the US, and very few studies have used a rigorous approach involving a comparator group or randomized controlled design. …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Proband Inclusion Criteria: * KCNQ1 Thr224Met or APOB R3527Q carrier * 18 years or older Proband Exclusion Criteria: * None Family Inclusion Criteria: * 1st degree relative of a KCNQ1 Thr224Met or APOB Arg3527Gln carrier Family Exclusion Criteria: * None
Contacts

Amber L Beitelshees, PharmD

410-706-0118

abeitels@som.umaryland.edu

CONTACT